Latest filing published 20 Apr 2016 for Acadia Pharmaceuticals INC, €52k.
Insider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -26.3%Entry US$1.86 · Close at T+365 US$1.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Leslie L. Iversen: trading record in brief
Leslie L. Iversen is a declared insider of Acadia Pharmaceuticals Inc, with filings sourced from SEC (Form 4). The record holds 25 filings, for trades running from 11 December 2006 to 18 April 2016.
In open-market terms, that means 1 purchase worth €3,631 on one side and 4 sales worth €4.1M on the other. On balance, insiders were net sellers of €4.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 20 option exercises. In 2016 alone, the filings show no purchases and 1 sale.
The record was last updated on 20 April 2016 with an option exercise (€52k) in Acadia Pharmaceuticals Inc. The most recent open-market purchase was published on 20 May 2009, 6,382 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Leslie L. Iversen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 33,697 shares@ US$1.755.0% of flowCommon StockSEC:0001415889-16-005582:0
- 33,697 shares@ US$33.5395.0% of flowCommon StockSEC:0001415889-16-005582:1
- 6,000 shares@ US$9.04Common StockSEC:0001415889-15-003713:0
- 10,000 shares@ US$9.04Common StockSEC:0001415889-15-003713:1
- 9,126 shares@ US$9.04Common StockSEC:0001415889-15-003713:2
- 4,874 shares@ US$1.75Common StockSEC:0001415889-15-003713:3
- 30,000 shares@ US$36.01Common StockSEC:0001415889-15-003713:4
- 8,500 shares@ US$11.00Common StockSEC:0001415889-15-002844:0
- 6,500 shares@ US$8.85Common StockSEC:0001415889-15-001975:0
- 7,627 shares@ US$8.85Common StockSEC:0001415889-15-001975:1
- 10,000 shares@ US$2.16Common StockSEC:0001415889-14-000035:0
- 20,500 shares@ US$2.16Common StockSEC:0001415889-14-000035:1
- 29,500 shares@ US$1.30Common StockSEC:0001415889-14-000035:2
- 60,000 shares@ US$25.03Common StockSEC:0001415889-14-000035:3
- 4,500 shares@ US$6.10Common StockSEC:0001415889-13-001821:0
- 10,000 shares@ US$1.30Common StockSEC:0001415889-13-001821:1
- 45,500 shares@ US$1.30Common StockSEC:0001415889-13-001821:2
- 60,000 shares@ US$22.92Common StockSEC:0001415889-13-001821:3
- 4,500 shares0Common StockSEC:0001415889-13-000294:0
- 3,000 shares@ US$1.65Common StockSEC:0001181431-09-026049:0Canonical exit: 16 Aug 2009 (T+90)
- 1,000 shares0Common StockSEC:0001181431-08-049964:0
- 1,000 shares0Common StockSEC:0001181431-08-049964:1
- 1,000 shares@ US$1.20Common StockSEC:0001181431-08-017954:0
- 3,000 shares@ US$0.50Common StockSEC:0001181431-06-069487:0
24 of 24 declarations
